|
Mildvan, Donna; Spritzler, John; Grossberg, Sidney E et al. (2005) Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. Clin Infect Dis 40:853-8
|
|
Breen, E C; McDonald, M; Fan, J et al. (2000) Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons. Clin Diagn Lab Immunol 7:769-73
|
|
Aziz, N; Nishanian, P; Mitsuyasu, R et al. (1999) Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 6:89-95
|
|
Plaeger, S; Bass, H Z; Nishanian, P et al. (1999) The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin Immunol 90:238-46
|
|
Fahey, J L (1998) Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection. Clin Diagn Lab Immunol 5:597-603
|
|
Shen, L P; Sheridan, P; Cao, W W et al. (1998) Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology. J Immunol Methods 215:123-34
|
|
van der Meijden, M; Gage, J; Breen, E C et al. (1998) IL-6 receptor (CD126'IL-6R') expression is increased on monocytes and B lymphocytes in HIV infection. Cell Immunol 190:156-66
|
|
Nishanian, P; Aziz, N; Chung, J et al. (1998) Oral fluids as an alternative to serum for measurement of markers of immune activation. Clin Diagn Lab Immunol 5:507-12
|
|
Martinez-Maza, O; Widney, D; van der Meijden, M et al. (1998) Immune dysfunction and the pathogenesis of AIDS-associated non-Hodgkin's lymphoma. Mem Inst Oswaldo Cruz 93:373-81
|
|
Fahey, J L; Taylor, J M; Manna, B et al. (1998) Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12:1581-90
|
Showing the most recent 10 out of 17 publications
